secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2022-01-03T23:59:59+00:00
Accession:  0001493152-22-000042
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical appoints Scott Neils as interim CFO; Greg Jensen departs effective Jan 3, 2022
--------------------------------------------------------------------------------

- Greg Jensen, VP Finance and CFO, terminated effective January 3, 2022.
- Scott Neils, previously Controller since August 2019, appointed Interim CFO.
- Neils receives $300,000 base salary, 35% target bonus, 109,164 options and 88,983 RSUs.
- Jensen expected to enter standard separation agreement with severance per employment contract.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/0001493152-22-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222000042/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer